Atlas Trials

Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa

Clinical trial NCT01538862 · COMPLETED

Trial details

NCT number
NCT01538862
Sponsor
Vanderbilt University Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Dystrophic Epidermolysis Bullosa
Start date
2012-02-01
Primary completion
2014-10-01
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.